U.S. National Trends in the Use of Antipsychotics During Office Visits, 1998–2002

References

• Hermann RC, Yang D, Ettner S, Marcus S, Yoon C, Melissa A: Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997. Psychiatr Serv 2002; 53:425–430
   PubMed Web of Science ®Google Scholar
• Van Brunt DL, Gibson PJ, Ramsey JL, Obenchain R: Outpatient use of major antipsychotic drugs in ambulatory care settings in the United States, 1997-2000. MedGenMed 2003; 5:16
   PubMedGoogle Scholar
• Miller AL, Chiles JA, Chiles JK, Crismon ML, Rush AJ, Shon SP:The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. J Clin Psychiatry 1999; 60:649–57
   PubMed Web of Science ®Google Scholar
• Miller AL, Hall CS, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Ereshefsky L, Essock SM, Finnerty M, Marder SR, Miller del D, McEvoy JP, Rush AJ, Saeed SA, Schooler NR, Shon SP, Stroup S, Tarin-Godoy B: The Texas Medication Algorithm Project antipsychotic algorithm for schizo-phrenia:2003 update. J Clin Psychiatry 2004; 65:500–8
   PubMed Web of Science ®Google Scholar
• Bagnall AM, Jones L, Ginnelly L, Lewis R, Glanville J, Gilbody S,Davies L, Torgerson D, Kleijnen J: A systematic review of atypi-cal antipsychotic drugs in schizophrenia. Health Technol Assess 2003; 7:1–193
   PubMedGoogle Scholar
• National Ambulatory Medical Care Surveys Public-Use Data Files (micro-data). Available at: ftp://ftp.cdc.gov/pub/ Health_Statistics/NCHS/Datasets/NAMCS/ Retrieved: February 1,2005
   Google Scholar
• National Center for Health Statistics, Bryant E., Shimizu I: Sam-ple design,sampling variance, and estimation procedures: for the National Ambulatory Medical Care Survey. Vital Health Stat 1988; 2:108
   Google Scholar
• Koch H, Cambell W: The collection and processing of drug infor-mation' National Center for Health Statistics. Vital Health Stat 1982; 2(90)
   Google Scholar
• Physician Desk Reference. Montvale, NJ: Medical Economics, 2004
   Google Scholar
• SAS. In: SAS/STAT user's guide release 6.03 edition. Cary, NC: SAS Institute Inc, 1992
   Google Scholar
• Shah By, Barnwell BG, Bieler GS: SUDAAN User's Manual. Release 7.5. Research Triangle Park, NC: Research Triangle Institute, 1997
   Google Scholar
• Hing E, Gousen S, Shimizu I, Burt C: Guide to using masked design variables to estimate standard errors in public use files of the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. Inquiry 2003; 40:401–15
   PubMed Web of Science ®Google Scholar
• Rosenheck R, Leslie D, Sernyak M: From clinical trials to real-world practice: Use of atypical antipsychotic medication nation-ally in the Department of Veterans Affairs. Med Care 2001; 39:302–8
   PubMed Web of Science ®Google Scholar
• Barbui C, Danese A, Guiana G, Mapelli L, Miele L, Monzani E, Percudani M: Prescribing second-generation antipsychotics and the evolving standard of care in Italy. Pharmacopsychiatry 2002; 35:239–243
   Google Scholar
• Konstantinos N, Fountoulakis, Ioannis Nimatoudis, Apostolos, Kaprinis G: Off-label indications for a typical antipsychotics: A systematic review. Ann Gen Hosp Psychiatry 2004; 3:4–13
   Google Scholar
• Alexopoulos G, Streim J, Carpenter D, Docherty J: The expert consensus panel for using antipsychotic agents in older patients-Introduction: Methods,commentary, and summary. J Clin Psychi-atry 2004; 65\(suppl 2):1–105
   Google Scholar
• Mossman D, Lehrer DS: Conventional and atypical antipsychot-ics and the evolving standard of care. Psychiatr Serv 2000; 51:1528–1535
   PubMedGoogle Scholar
• Zito JM, Safer DJ: Sources of data for pharmacoepidemiological studies of child and adolescent psychiatric disorders. J Child Ado-lesc Psychopharmacol 1997; 7:237–53
   Google Scholar
• Bhatara VS, Feil M, Hoagwood K, Vitiello B, Zima B: Datapoints: trends in combined pharmacotherapy with stimulants for children. Psychiatr Serv 2002; 53:244
   Google Scholar